Telerehabilitation for patients with idiopathic pulmonary fibrosis
The Effectiveness of Synchronized Online and Video-based Exercise Programs in Patients With Idiopathic Pulmonary Fibrosis
This study is testing two different online exercise programs to see which one helps people with idiopathic pulmonary fibrosis feel better after 8 weeks of workouts.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 44 (estimated) |
| Ages | 18 Years to 75 Years |
| Sex | All |
| Sponsor | Istanbul Medipol University Hospital Academic / other |
| Locations | 1 site (Istanbul, Zeytinburnu) |
| Trial ID | NCT05190211 on ClinicalTrials.gov |
What this trial studies
This study aims to evaluate the effectiveness of two different telerehabilitation exercise programs for patients diagnosed with idiopathic pulmonary fibrosis (IPF). Participants will be randomly assigned to either the Telerehabilitation Exercise Group, which receives online exercises with a physiotherapist, or the Video Group, which follows a pre-recorded exercise video. Both groups will engage in an 8-week exercise program, with weekly follow-ups to monitor their progress. The goal is to determine which approach is more beneficial for improving patient outcomes.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18-75 diagnosed with idiopathic pulmonary fibrosis who experience dyspnea on exertion and are in a stable clinical state.
Not a fit: Patients with severe comorbidities, unstable coronary artery disease, or those requiring high flow oxygen therapy may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the rehabilitation options available for patients with IPF, potentially improving their quality of life and physical function.
How similar studies have performed: While telerehabilitation is a growing field, this specific approach for IPF patients is relatively novel and has not been extensively tested in previous studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Being between the ages of 18-75 * Having a diagnosis of IPF disease diagnosed according to the following clinical diagnostic criteria according to the American Thoracic and European Respiratory Societies (ATS-ERS) * Presence of dyspnea on exertion * Stable clinical state at the time of admission without infection or exacerbation in the previous 4 weeks Exclusion Criteria: * Patients with severe comorbid diseases, unstable coronary artery disease, collagen vascular diseases and needing high flow oxygen therapy (˃ 3-4 L \\min). * A history of effort-related syncope or any comorbidity (such as severe orthopedic or neurological deficits or unstable heart disease) that precludes exercise training. * Participation in a pulmonary rehabilitation program within the past 12 months.
Where this trial is running
Istanbul, Zeytinburnu
- Yedikule Chest Disease Hospital — Istanbul, Zeytinburnu, Turkey (Türkiye) (Recruiting)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.